E-liac™
STENT GRAFT SYSTEM
Hypogastric Artery Matters.
Product Overview
1. VISIBILITY
X-ray markers at various points allow safe positioning. The special E-marker indicates orientation of the side branch.
2. CONFORMABILITY
The asymmetric spring configuration allows good alignment to the vessel’s shape.
3. CONNECTION
A specially designed spring ensures the connection of the covered stent to the pre-cannulated side branch.
4. INDIVIDUALITY
Various proximal and distal diameters together with different lengths cover a wide range of anatomies for an individual treatment.
1. GUIDANCE
Axial and lateral lumen for guide wire introduction.
2. FLEXIBILITY
The catheter is designed for safe and precise advancement even in tortuous anatomies.
3. SMOOTH DELIVERY
The hydrophilic coating eases introduction and advancement of the system.
4. ORIENTATION
Tactile marking indicates orientation of the side branch and enables precise deployment of the stent graft.
5. EASY DEPLOYMENT
The Squeeze-to-Release mechanism allows gradual or continuous release with minimum effort.
6. CONTROL
The control handle secures the position of the delivery system during the procedure.
7. FUNCTIONALITY
The end cap of the delivery system contains various functions: guidance for the central and lateral guide wire as well as the release mechanism for the distal stent graft fixation.
Clinical Evidence




PLIANTII Study1 (N=295)
Prospective, observational multicenter study including the largest real world patient population to date treated with the E-liac™ Stent Graft System.
Main Outcomes from Latest Publications1,2,3,4
All of these studies show high technical success rates for the E-liac™ Stent Graft, with excellent long-term outcomes.
The E-liac™ Stent Graft is a feasible, safe, and durable solution for the treatment of complex aorto-iliac aneurysms.
E-liac™ showed a significant decrease in maximum diameter of the aortic aneurysmal sac from baseline.
E-tegra™ & E-liac™
One Solution for your
Aorto Iliac Needs.

Additional Resources
Explore additional resources for E-liac below. For further information or to contact a sales associate in your area, contact us.
Product Highlights
- E-liac Instructions for use (IFU 904225)
- Mylonas et.al. (2016). A multicenter 12-month experience with a new iliac side-branched device for revascularization of hypogastric arteries. J Vasc Surg, 64(6), 1652-1659.e1.
- Anton et.al. (2018). Initial Experience with the E-liac Iliac Branch Device for the Endovascular Aortic Repair of Aorto-iliac Aneurysm. Cardiovasc Intervent Radiol, 41(5), 683-6919.
- Brunkwall et.al. (2019). Prospective Study of the Iliac Branch Device E-liac in Patients with Common Iliac Artery Aneurysms: 12 Month Results. EJVS. doi:10.1016/j.ejvs.2019.06.020.
Clinical Evidence
- Oberhuber A et al., A Prospective, Multicentre Registry on Thirty Day and One Year Outcomes of the E-liac Stent Graft System in Patients with Unilateral or Bilateral Aorto-iliac or Iliac Aneurysms: The PLIANTII Study, European Journal of Vascular and Endovascular Surgery, https://doi.org/10.1016/j.ejvs.2025.02.029.
- Yazar O, Willems S, Zonnebeld N, Salemans PB, Wong C, Bouwman LH. Single-Center Mid-term Experience with E-Liac Branched Device from Artivion®.
Ann Vasc Surg. 2025 Jan;110(Pt B):176-182. doi: 10.1016/j.avsg.2024.05.042. Epub 2024 Jul 17. PMID: 39029895. - San Norberto, E.M.; Revilla,Á.; Brizuela, J.A.; del Blanco, I.;Fernández-Bello, S.; Taylor, J.H. Eleven Years of Experience in the Treatment of Aortoiliac Aneurysm with the E-Liac Stent-Graft System. J. Clin. Med. 2025,14, 8203. https://doi.org/10.3390/jcm14228203.
- Anton et.al. (2018). Initial Experience with the E-liac Iliac Branch Device for the Endovascular Aortic Repair of Aorto-iliac Aneurysm. Cardiovasc Intervent Radiol, 41(5), 683-6919.
- Turchino D, Peluso A, Accarino G, Accarino G, De Rosa C, D’Angelo A, Machi P, Mirabella D, Pecoraro F, Del Guercio L, Bracale UM, Dinoto E. A Multicenter Experience of Three Different “Iliac Branched” Stent Grafts for the Treatment of Aorto-Iliac And/Or Iliac Aneurysms. Ann Vasc Surg. 2023 Aug;94:331-340. doi: 10.1016/j.avsg.2023.02.033. Epub 2023 Mar 13. PMID: 36921795.
Bench test data on file at Jotec GmbH. Data are not indicative of clinical performance.
All products and indications are not available/approved in all markets. All trademarks are owned by Artivion, Inc. or its subsidiaries. On-X Life Technologies, Inc., Jotec GmbH, and Ascyrus Medical GmbH are wholly owned subsidiaries of Artivion, Inc. MWENG0021.002. (2026-06)
| JOTEC GmbH, Lotzenäcker 23, 72379 Hechingen, Germany |
